Parallel Advisors’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
EAM
FCM
CCM
SHI
ACM
Parallel Advisors's TECX Position: Q2 2020 in Review
Parallel Advisors sold out of Tectonic Therapeutic (TECX) in Q2 2020, closing a stake of 47 shares — an estimated $8K sold.
Parallel Advisors first reported a position in TECX in Q1 2020 and held it in 1 quarter. The position peaked at $8K in Q1 2020. 98 funds tracked by Wall St. Rank hold TECX as of Q2 2020.
- Parallel Advisors reported no remaining Tectonic Therapeutic position as of Q2 2020 after selling out during the quarter.
- Parallel Advisors sold 47 Tectonic Therapeutic shares in Q2 2020, an estimated $8K.
- Parallel Advisors first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 1 quarter.
- Parallel Advisors's Tectonic Therapeutic position peaked at $8K in Q1 2020.
- 98 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2020.
Based on Parallel Advisors's 13F filing for Q2 2020, filed 16 Jul 2020.